Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

5

Number of overlapping holdings

16.7%

% of MEDX's 30 holdings also in THNR

21.7%

% of THNR's 23 holdings also in MEDX

Overlap by Weight
Sector Drift (MEDX minus THNR)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in THNR
Overlap
ELI LILLY & CO 16.8% 15.7% 15.7%
ASTRAZENECA PLC-SPONS ADR 5.6% 4.7% 4.7%
AMGEN INC 6.3% 4.6% 4.6%
PFIZER INC 4.0% 4.6% 4.0%
MERCK & CO. INC. 3.6% 4.7% 3.6%

Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to THNR
ABBVIE INC 9.6%
NOVARTIS AG-ADR 6.6%
BRISTOL-MYERS SQUIBB CO 6.5%
JOHNSON & JOHNSON 5.1%
ALNYLAM PHARMACEUTICALS INC 4.7%
ALKERMES PLC 4.7%
REGENERON PHARMACEUTICALS 2.8%
GLAXOSMITHKLINE PLC-SPON ADR 2.7%
BIOGEN IDEC INC 2.6%
CRISPR THERAPEUTICS AG 2.4%
MEDX Underweight Relative to THNR
NOVO-NORDISK A/S-SPONS ADR -13.9%
CHUGAI PHARMACEUTICAL CO LTD -5.2%
WEST PHARMACEUTICAL SERVICES -5.1%
THERMO FISHER SCIENTIFIC INC -5.0%
ROCHE HOLDING LTD -4.7%
INNOVENT BIOLOGICS, INC. -4.7%
TEVA PHARMACEUTICAL-SP ADR -4.5%
HIMS & HERS HEALTH, INC. CLASS A -3.6%
MITSUBISHI CHEMICAL HOLDINGS -3.5%
ZEALAND PHARMA A/S -2.7%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY